Clinical Trial Update: Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

View source ↗

Summary

This document reports the completion of a special drug use investigation for Paxil (paroxetine) at 20 mg/day in the treatment of panic disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• PAXIL (paroxetine hydrochloride)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Panic Disorder | Status: COMPLETED